FDA Drug Recalls

Recalls / Class II

Class IID-0015-2019

Product

Magnesium Sulfate in Water for Injection (0.325 mEq Mg++/mL) 40 mg/mL, 20 g Total, 500 mL Single-Dose Container bag, Rx only, Hospira, Inc. Lake Forest, IL 60045 USA, NDC 0409-6729-03.

Brand name
Magnesium Sulfate In Water
Generic name
Magnesium Sulfate In Water
Active ingredient
Magnesium Sulfate Heptahydrate
Route
Intravenous
NDCs
0409-2050, 0409-6730, 0409-6729, 0409-4121, 0409-3164, 0409-5239
FDA application
NDA020309
Affected lot / code info
Lot: 87904FW, Exp. 1MAR2020

Why it was recalled

Correct Labeled Product Mispack: confirmed report involving a single unit of properly labeled Heparin in 0.45% Sodium Chloride for Injection (NDC 0409-7651-03, Lot 87903FW) that was found inside a case of Magnesium Sulfate in Water for Injection.

Recalling firm

Firm
Pfizer Inc.
Manufacturer
Hospira, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
235 E 42nd St, New York, New York 10017-5703

Distribution

Quantity
94,752 bags
Distribution pattern
Nationwide in the USA and Puerto Rico

Timeline

Recall initiated
2018-10-03
FDA classified
2018-10-11
Posted by FDA
2018-10-17
Terminated
2020-10-02
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0015-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.